Australia: Health Agencies Issue Joint Guidance Regarding Clinical Trials and COVID-19

On March 24, 2020, Australia’s state and territory Departments of Health, the Therapeutic Goods Administration (TGA), National Health and Medical Research Council (NHMRC) and the Clinical Trials Project Reference Group (CTPRG) issued: COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors (Word 36 KB). The guidance covers items such as participant safety, trial management and new clinical trials, as well as other information